FactSet to Participate in Credit Suisse 24th Annual Technology Conference

NORWALK, Conn., Nov. 23, 2020 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS | NASDAQ: FDS), a global provider of integrated financial information, analytical applications, and industry-leading services, today announced that it will participate in Credit Suisse’s 24th Annual Technology Conference on Monday, November 30, 2020.

Phil Snow, Chief Executive Officer, will participate in a fireside chat at 4:20 p.m. EST. A live webcast will be available on FactSet’s investor relations website. A replay will also be available for one year following the event.

About FactSet

FactSet® (NYSE:FDS | NASDAQ: FDS) delivers superior content, analytics, and flexible technology to help more than 133,000 users see and seize opportunity sooner. We give investment professionals the edge to outperform with informed insights, workflow solutions across the portfolio lifecycle, and industry-leading support from dedicated specialists. We're proud to have been recognized with multiple awards for our analytical and data-driven solutions and repeatedly scored 100 by the Human Rights Campaign® Corporate Equality Index for our LGBTQ+ inclusive policies and practices.  Subscribe to our thought leadership blog to get fresh insight delivered daily at insight.factset.com. Learn more at www.factset.com and follow us on Twitter: www.twitter.com/factset.

FactSet Media & Investor Relations Contact:                         Rima Hyder                                        857.265.7523                                [email protected]

Source: FactSet Research Systems Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FactSet Research Systems (FDS) PT Raised to $275 at BMO Capital
• Ice Code Games signs Letter of Intent to acquire AMIHAN and reposition as a listed Real-World Assets platform
• Boardman Family Chiropractic Highlights Non-Surgical Spinal Decompression Therapy For Ahwatukee & Phoenix Area Residents Struggling With Back Pain, Sciatica, And Disc-Related Conditions